222 related articles for article (PubMed ID: 23116443)
1. Membrane interacting peptides: from killers to helpers.
Dufourc EJ; Buchoux S; Toupé J; Sani MA; Jean-François F; Khemtémourian L; Grélard A; Loudet-Courrèges C; Laguerre M; Elezgaray J; Desbat B; Odaert B
Curr Protein Pept Sci; 2012 Nov; 13(7):620-31. PubMed ID: 23116443
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in computational modeling of α-helical membrane-active peptides.
Polyansky AA; Chugunov AO; Vassilevski AA; Grishin EV; Efremov RG
Curr Protein Pept Sci; 2012 Nov; 13(7):644-57. PubMed ID: 23363529
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides.
Shai Y
Biochim Biophys Acta; 1999 Dec; 1462(1-2):55-70. PubMed ID: 10590302
[TBL] [Abstract][Full Text] [Related]
4. Structure, activity and interactions of the cysteine deleted analog of tachyplesin-1 with lipopolysaccharide micelle: Mechanistic insights into outer-membrane permeabilization and endotoxin neutralization.
Saravanan R; Mohanram H; Joshi M; Domadia PN; Torres J; Ruedl C; Bhattacharjya S
Biochim Biophys Acta; 2012 Jul; 1818(7):1613-24. PubMed ID: 22464970
[TBL] [Abstract][Full Text] [Related]
5. Role of Lipid Composition, Physicochemical Interactions, and Membrane Mechanics in the Molecular Actions of Microbial Cyclic Lipopeptides.
Balleza D; Alessandrini A; Beltrán García MJ
J Membr Biol; 2019 Jun; 252(2-3):131-157. PubMed ID: 31098678
[TBL] [Abstract][Full Text] [Related]
6. Deletion of all cysteines in tachyplesin I abolishes hemolytic activity and retains antimicrobial activity and lipopolysaccharide selective binding.
Ramamoorthy A; Thennarasu S; Tan A; Gottipati K; Sreekumar S; Heyl DL; An FY; Shelburne CE
Biochemistry; 2006 May; 45(20):6529-40. PubMed ID: 16700563
[TBL] [Abstract][Full Text] [Related]
7. Self-assembly and interactions of short antimicrobial cationic lipopeptides with membrane lipids: ITC, FTIR and molecular dynamics studies.
Sikorska E; Dawgul M; Greber K; Iłowska E; Pogorzelska A; Kamysz W
Biochim Biophys Acta; 2014 Oct; 1838(10):2625-34. PubMed ID: 24978107
[TBL] [Abstract][Full Text] [Related]
8. The impact of peptides on lipid membranes.
Khandelia H; Ipsen JH; Mouritsen OG
Biochim Biophys Acta; 2008; 1778(7-8):1528-36. PubMed ID: 18358231
[TBL] [Abstract][Full Text] [Related]
9. The importance of membrane defects-lessons from simulations.
Bennett WF; Tieleman DP
Acc Chem Res; 2014 Aug; 47(8):2244-51. PubMed ID: 24892900
[TBL] [Abstract][Full Text] [Related]
10. Peptide:lipid ratio and membrane surface charge determine the mechanism of action of the antimicrobial peptide BP100. Conformational and functional studies.
Manzini MC; Perez KR; Riske KA; Bozelli JC; Santos TL; da Silva MA; Saraiva GK; Politi MJ; Valente AP; Almeida FC; Chaimovich H; Rodrigues MA; Bemquerer MP; Schreier S; Cuccovia IM
Biochim Biophys Acta; 2014 Jul; 1838(7):1985-99. PubMed ID: 24743023
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of trivalent cyclic hexapeptides to induce lipid clustering in PG/PE membranes correlates with their antimicrobial activity.
Finger S; Kerth A; Dathe M; Blume A
Biochim Biophys Acta; 2015 Nov; 1848(11 Pt A):2998-3006. PubMed ID: 26367060
[TBL] [Abstract][Full Text] [Related]
12. Arginine/Tryptophan-Rich Cyclic α/β-Antimicrobial Peptides: The Roles of Hydrogen Bonding and Hydrophobic/Hydrophilic Solvent-Accessible Surface Areas upon Activity and Membrane Selectivity.
Bagheri M; Amininasab M; Dathe M
Chemistry; 2018 Sep; 24(53):14242-14253. PubMed ID: 29969522
[TBL] [Abstract][Full Text] [Related]
13. Pore formation induced by an antimicrobial peptide: electrostatic effects.
Jean-François F; Elezgaray J; Berson P; Vacher P; Dufourc EJ
Biophys J; 2008 Dec; 95(12):5748-56. PubMed ID: 18820233
[TBL] [Abstract][Full Text] [Related]
14. The effect of cyclization of magainin 2 and melittin analogues on structure, function, and model membrane interactions: implication to their mode of action.
Unger T; Oren Z; Shai Y
Biochemistry; 2001 May; 40(21):6388-97. PubMed ID: 11371201
[TBL] [Abstract][Full Text] [Related]
15. New lytic peptides based on the D,L-amphipathic helix motif preferentially kill tumor cells compared to normal cells.
Papo N; Shai Y
Biochemistry; 2003 Aug; 42(31):9346-54. PubMed ID: 12899621
[TBL] [Abstract][Full Text] [Related]
16. Characterization of antimicrobial peptide activity by electrochemical impedance spectroscopy.
Chang WK; Wimley WC; Searson PC; Hristova K; Merzlyakov M
Biochim Biophys Acta; 2008 Oct; 1778(10):2430-6. PubMed ID: 18657512
[TBL] [Abstract][Full Text] [Related]
17. Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes.
Matsuzaki K
Biochim Biophys Acta; 1999 Dec; 1462(1-2):1-10. PubMed ID: 10590299
[TBL] [Abstract][Full Text] [Related]
18. The interaction of antimicrobial peptides with membranes.
Travkova OG; Moehwald H; Brezesinski G
Adv Colloid Interface Sci; 2017 Sep; 247():521-532. PubMed ID: 28606715
[TBL] [Abstract][Full Text] [Related]
19. Lipid topology and electrostatic interactions underpin lytic activity of linear cationic antimicrobial peptides in membranes.
Paterson DJ; Tassieri M; Reboud J; Wilson R; Cooper JM
Proc Natl Acad Sci U S A; 2017 Oct; 114(40):E8324-E8332. PubMed ID: 28931578
[TBL] [Abstract][Full Text] [Related]
20. Simulating the mechanism of antimicrobial lipopeptides with all-atom molecular dynamics.
Horn JN; Romo TD; Grossfield A
Biochemistry; 2013 Aug; 52(33):5604-10. PubMed ID: 23875688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
